Istituto di Candiolo- Fondazione del Piemonte per l'Oncologia

Candiolo 10060

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), DLBCL, FL, High-grade B-cell Lymphoma (HGBCL), Indolent B-cell Non-Hodgkin Lymphoma (iNHL), Leiomyosarcoma, MCL, Marginal Zone Lymphoma (MZL), Metastatic Non-Small Cell Lung Cancer, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Small Lymphocytic Lymphoma (SLL)

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) — Running, not enrolling